Alterity Therapeutics (ATHE) has announced the appointment of Abby Macnish Niven as Alterity’s Company Secretary following her appointment as CFO of Alterity. Ms Macnish Niven assumes the role of Company Secretary from Mr Phillip Hains effective on 18 November 2024. Macnish Niven was appointed as CFO on 30 September 2024 and has extensive experience in private wealth management with groups including ANZ, UBS and Ord Minett.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATHE:
- Alterity Therapeutics announces presentation on bioMUSE study
- Alterity Therapeutics announces new publication on ATH434
- Alterity Therapeutics reports cash balance of A$9.28M as of September 30
- Alterity Therapeutics to Present at Healthcare Summit
- Alterity Therapeutics presents data on neuroprotection of ATH434